Epimetabolites: discovering metabolism beyond building and burning

Current Opinion in Chemical Biology

Volumn 36, Issue , 2017, Pages 70-76

  Showalter, Megan R ^a   Cajka, Tomas ^a   Fiehn, Oliver ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; NITRIC OXIDE;

BIOLOGICAL FUNCTIONS; BIOSYNTHESIS; CANCER CELL; CATABOLISM; CELL INVASION; COMPUTER MODEL; EPIGENETICS; GAS CHROMATOGRAPHY; HISTONE DEMETHYLATION; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITE; METABOLOMICS; NONHUMAN; PREDICTION; REVIEW; STEM CELL; TISSUE INJURY; TUMOR INVASION; CHEMICAL STRUCTURE; CHROMATOGRAPHY; METABOLOME; PROCEDURES; SOFTWARE;

CHROMATOGRAPHY; HUMANS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MOLECULAR STRUCTURE; SOFTWARE;

EID: 85012295540     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2017.01.012     Document Type: Review

References (52)

1. 1 da Silva, R.R., Dorrestein, P.C., Quinn, R.A., Illuminating the dark matter in metabolomics. Proc Natl Acad Sci 112 (2015), 12549–12550.
2. 2 O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277 (2015), 32–48.
3. 3 Linster, C.L., Van Schaftingen, E., Hanson, A.D., Metabolite damage and its repair or pre-emption. Nat Chem Biol 9 (2013), 72–80.
4. 4• Rappaport, S.M., Barupal, D.K., Wishart, D., Vineis, P., Scalbert, A., The blood exposome and its role in discovering causes of disease. Environ Health Perspect 122 (2014), 769–774 This paper is a seminal contribution due to its comprehensive investigation of exposome compounds present in human blood, and ranges of concentrations that tightly overlap with levels of endogenous metabolites.
5. 5 Santagata, S., Eberlin, L.S., Norton, I., Calligaris, D., Feldman, D.R., Ide, J.L., Liu, X., Wiley, J.S., Vestal, M.L., Ramkissoon, S.H., Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci 111 (2014), 11121–11126.
6. 6 Nowicki, S., Gottlieb, E., Oncometabolites: tailoring our genes. FEBS J 282 (2015), 2796–2805.
7. 7 Li, X., Gianoulis, T.A., Yip, K.Y., Gerstein, M., Snyder, M., Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell 143 (2010), 639–650.
8. 8 O'Meara, T.R., Veri, A.O., Polvi, E.J., Li, X., Valaei, S.F., Diezmann, S., Cowen, L.E., Mapping the Hsp90 genetic network reveals ergosterol biosynthesis and phosphatidylinositol-4-kinase signaling as core circuitry governing cellular stress. PLoS Genet, 12, 2016, e1006142.
9. 9• Serhan, C.N., Pro-resolving lipid mediators are leads for resolution physiology. Nature 510 (2014), 92–101 This review provides a very good overview over the roles and regulation of oxylipins and resolvins in inflammation.
10. 10•• Yore, M.M., Syed, I., Moraes-Vieira, P.M., Zhang, T., Herman, M.A., Homan, E.A., Patel, R.T., Lee, J., Chen, S., Peroni, O.D., Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159 (2014), 318–332 The authors here report on the discovery and validation of FAHFA lipids and their direct involvement in insulin resistance and sensitivity, with a prospect of using this new class of lipid epimetabolites for treatment of type 2 diabetes.
11. 11 Su, X., Wellen, K.E., Rabinowitz, J.D., Metabolic control of methylation and acetylation. Curr Opin Chem Biol 30 (2016), 52–60.
12. 12 Laursen, T., Moller, B.L., Bassard, J.E., Plasticity of specialized metabolism as mediated by dynamic metabolons. Trends Plant Sci 20 (2015), 20–32.
13. 13 Cheynier, V., Comte, G., Davies, K.M., Lattanzio, V., Martens, S., Plant phenolics: recent advances on their biosynthesis, genetics, and ecophysiology. Plant Physiol Biochem 72 (2013), 1–20.
14. 14 Johnson, J.E., Reyes, F.E., Polaski, J.T., Batey, R.T., B-12 cofactors directly stabilize an mRNA regulatory switch. Nature 492 (2012), 133–137.
15. 15 Henkin, T.M., Riboswitch RNAs: using RNA to sense cellular metabolism. Genes Dev 22 (2008), 3383–3390.
16. 16 Gorrochategui, E., Jaumot, J., Lacorte, S., Tauler, R., Data analysis strategies for targeted and untargeted LC–MS metabolomic studies: overview and workflow. TrAC Trends Anal Chem 82 (2016), 425–442.
17. 17 Misra, B.B., der Hooft, J.J.J., Updates in metabolomics tools and resources: 2014–2015. Electrophoresis 37 (2016), 86–110.
18. 18 Ostermann, A.I., Willenberg, I., Schebb, N.H., Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC–MS/MS. Anal Bioanal Chem 407 (2015), 1403–1414.
19. 19 Willenberg, I., Ostermann, A.I., Schebb, N.H., Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC–MS analysis of oxylipins. Anal Bioanal Chem 407 (2015), 2675–2683.
20. 20 Gouveia-Figueira, S., Nording, M.L., Validation of a tandem mass spectrometry method using combined extraction of 37 oxylipins and 14 endocannabinoid-related compounds including prostamides from biological matrices. Prostaglandins Other Lipid Mediators 121 (2015), 110–121.
21. 21 Ma, Y., Kind, T., Vaniya, A., Gennity, I., Fahrmann, J.F., Fiehn, O., An in silico MS/MS library for automatic annotation of novel FAHFA lipids. J Cheminf, 7, 2015, 1.
22. 22 Sreekumar, A., Poisson, L.M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R.J., Li, Y., Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 (2009), 910–914.
23. 23 Khan, A.P., Rajendiran, T.M., Ateeq, B., Asangani, I.A., Athanikar, J.N., Yocum, A.K., Mehra, R., Siddiqui, J., Palapattu, G., Wei, J.T., et al. The role of sarcosine metabolism in prostate cancer progression. Neoplasia 15 (2013), 491–501.
24. 24•• Sperber, H., Mathieu, J., Wang, Y., Ferreccio, A., Hesson, J., Xu, Z., Fischer, K.A., Devi, A., Detraux, D., Gu, H., The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat Cell Biol 17 (2015), 1523–1535 This report unequivocally demonstrates that controlling the levels of the epimetabolite methyl-nicotinamide are required and sufficient to mediate the epigenetic status of pluripotent stem cells.
25. 25 Xuan, C., Tian, Q.-W., Li, H., Zhang, B.-B., He, G.-W., Lun, L.-M., Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: a meta-analysis based on 4713 participants. Eur J Prev Cardiol 23 (2016), 502–510.
26. 26 Martens-Lobenhoffer, J., Bode-Böger, S.M., Amino acid N-acetylation: metabolic elimination of symmetric dimethylarginine as symmetric N α-acetyldimethylarginine, determined in human plasma and urine by LC–MS/MS. J Chromatogr B 975 (2015), 59–64.
27. 27 Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17 (2010), 225–234.
28. 28 Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462 (2009), 739–744.
29. 29 Intlekofer, A.M., Dematteo, R.G., Venneti, S., Finley, L.W.S., Lu, C., Judkins, A.R., Rustenburg, A.S., Grinaway, P.B., Chodera, J.D., Cross, J.R., Hypoxia induces production of L-2-hydroxyglutarate. Cell Metab 22 (2015), 304–311.
30. 30•• Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483 (2012), 484–488 The authors show an enantiomeric difference of the effect of R/S-2-hydroxyglutarate controlling important aspects of cellular metabolism.
31. 31 Cajka, T., Fiehn, O., Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal Chem 88 (2016), 524–545.
32. 32 Pluskal, T., Castillo, S., Villar-Briones, A., Orešič, M., MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics, 11, 2010, 1.
33. 33 Libiseller, G., Dvorzak, M., Kleb, U., Gander, E., Eisenberg, T., Madeo, F., Neumann, S., Trausinger, G., Sinner, F., Pieber, T., IPO: a tool for automated optimization of XCMS parameters. BMC Bioinformatics, 16, 2015, 1.
34. 34•• Tsugawa, H., Cajka, T., Kind, T., Ma, Y., Higgins, B., Ikeda, K., Kanazawa, M., VanderGheynst, J., Fiehn, O., Arita, M., MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods 12 (2015), 523–526 This is the recommended, freely available software for processing untargeted metabolomics data. The paper shows the utility for removing false positive peaks and compound identification, including large-scale data analyses.
35. 35 Kind, T., Liu, K.-H., Lee, D.Y., DeFelice, B., Meissen, J.K., Fiehn, O., LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat Methods 10 (2013), 755–758.
36. 36 Vinaixa, M., Schymanski, E.L., Neumann, S., Navarro, M., Salek, R.M., Yanes, O., Mass spectral databases for LC/MS-and GC/MS-based metabolomics: State of the field and future prospects. TrAC Trends Anal Chem 78 (2016), 23–35.
37. 37 Kind, T., Fiehn, O., Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics, 7, 2006, 1.
38. 38 Tsugawa, H., Kind, T., Nakabayashi, R., Yukihira, D., Tanaka, W., Cajka, T., Saito, K., Fiehn, O., Arita, M., Hydrogen rearrangement rules: computational MS/MS fragmentation and structure elucidation using MS-FINDER software. Anal Chem 88 (2016), 7946–7958.
39. 39 Dührkop, K., Böcker, S., Fragmentation trees reloaded. International Conference on Research in Computational Molecular Biology, Springer, 2015, 65–79.
40. 40 Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., HMDB 3.0—the human metabolome databasein 2013. Nucl Acids Res, 2012 gks1065.
41. 41• Jeffryes, J.G., Colastani, R.L., Elbadawi-Sidhu, M., Kind, T., Niehaus, T.D., Broadbelt, L.J., Hanson, A.D., Fiehn, O., Tyo, K.E.J., Henry, C.S., MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics. J Cheminf, 7, 2015, 1 Substrate promiscuity of enzymes is known for a long time, but no database captures such information in a comprehensive manner. The authors here show how the database was constructed and used and how closely the predicted compounds resemble known natural products.
42. 42 Ruttkies, C., Schymanski, E.L., Wolf, S., Hollender, J., Neumann, S., MetFrag relaunched: incorporating strategies beyond in silico fragmentation. J Cheminf, 8, 2016, 1.
43. 43 Ma, Y., Kind, T., Yang, D., Leon, C., Fiehn, O., MS2Analyzer: a software for small molecule substructure annotations from accurate tandem mass spectra. Anal Chem 86 (2014), 10724–10731.
44. 44 Dührkop, K., Shen, H., Meusel, M., Rousu, J., Böcker, S., Searching molecular structure databases with tandem mass spectra using CSI: FingerID. Proc Natl Acad Sci 112 (2015), 12580–12585.
45. 45• Allen, F., Pon, A., Wilson, M., Greiner, R., Wishart, D., CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucl Acids Res 42 (2014), W94–W99 At current, the MS/MS prediction capabilities of this software CFM-ID appears to slightly outperform alternative programs. This paper outlines the algorithms and assumptions behind it.
46. 46 Schymanski, E.L., Gerlich, M., Ruttkies, C., Neumann, S., Solving CASMI 2013 with MetFrag, MetFusion and MOLGEN-MS/MS. Mass Spectrom, 2014, 3:S0036.
47. 47 Bingol, K., Bruschweiler, R., Knowns and unknowns in metabolomics identified by multidimensional NMR and hybrid MS/NMR methods. Curr Opin Biotechnol 43 (2016), 17–24.
48. 48 Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., DuGar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.-M., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
49. 49 Koeth, R.A., Levison, B.S., Culley, M.K., Buffa, J.A., Wang, Z., Gregory, J.C., Org, E., Wu, Y., Li, L., Smith, J.D., γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab 20 (2014), 799–812.
50. 50 Collard, F., Baldin, F., Gerin, I., Bolsee, J., Noel, G., Graff, J., Veiga-da-Cunha, M., Stroobant, V., Vertommen, D., Houddane, A., et al. A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast. Nat Chem Biol 12 (2016), 601–607.
51. 51 Wikoff, W.R., Hanash, S., DeFelice, B., Miyamoto, S., Barnett, M., Zhao, Y., Goodman, G., Feng, Z., Gandara, D., Fiehn, O., Diacetylspermine is a novel prediagnostic serum biomarker for non-small-cell lung cancer and has additive performance with pro-surfactant protein B. J Clin Oncol 33 (2015), 3880–3886.
52. 52 Johnson, C.H., Dejea, C.M., Edler, D., Hoang, L.T., Santidrian, A.F., Felding, B.H., Ivanisevic, J., Cho, K., Wick, E.C., Hechenbleikner, E.M., Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab 21 (2015), 891–897.